Lataa...

The pharmacokinetics and dose proportionality of cilazapril

1 The pharmacokinetics and dose proportionality of cilazapril, an orally active angiotensin-converting enzyme (ACE) inhibitor, were investigated in a four-way randomized crossover study in 24 volunteers, over the 0.5 to 5 mg dose range intended for therapeutic use. 2 Plasma concentrations of cilazap...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Massarella, J., DeFeo, T., Lin, A., Limjuco, R., Brown, A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1989
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379748/
https://ncbi.nlm.nih.gov/pubmed/2527533
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!